CSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, Receives FDA and EMA Filing Acceptance

/PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) has accepted the company's...

Related Keywords

Australia ,Emmanuelle Lecomte Brisset ,Kim Odonohue ,Jimmy Baker ,Valerie Bomberger ,Global Head Of Regulatory Affairs ,Drug Administration ,Twitter ,European Medicines Agency ,European Union ,Biologics License Application ,Authorization Application ,Senior Vice President ,Global Head ,Regulatory Affairs ,Csl ,